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ABSTRACT
Herpes simplex virus type 1 (HSV-1) encodes five
immediate early (IE) polypeptides. This paper reports
the construction of a baculovirus vector which
expresses large amounts of Vmw110, the product of
IE gene 1. The expressed protein has been purified to
near homogeneity and has a mobility on SDS
polyacrylamide gels identical to that of Vmw110
produced during HSV-1 infection. Characterisation of
its properties indicated that it forms dimers and
perhaps higher order oligomers in solution and that the
purified protein binds to both single stranded and
double stranded calf thymus DNA cellulose columns.
However, filter binding experiments were unable to
detect any stable association of Vmw110 with DNA in
solution.
INTRODUCTION
The human pathogen herpes simplex virus type 1 (HSV-1) serves
as an excellent system to study several aspects of higher
eukaryotic molecular biology. Interpretation of the complete
sequence of the 150kb double stranded DNA genome has led
to the prediction of over 70 unique genes (1). On the basis of
the kinetics of synthesis and the effects of metabolic inhibitors,
viral gene expression has been divided into three temporal classes
termed immediate early (IE), early and late (reviewed in
references 2 and 3). At least three of the five IE gene products
are involved in the activation of transcription from early and late
gene promoters. This report concerns the product of IE gene 1,
which is known as Vmwl 10 or ICPO.
The role of Vmwl 10 in gene expression was first discovered
in transfection assays which demonstrated that it activated
expression from a wide variety of promoters in an apparently
non-specific fashion (4-7). In certain circumstances the activity
of Vmwl 10 was synergistic with that of another major HSV-1
IE polypeptide, Vmwl75 (ICP4). Construction of HSV-1 viruses
with deletions in the IE-1 coding region rather surprisingly
demonstrated that Vmwl 10 was not essential for viral growth
in tissue culture. However, such mutant viruses exhibited a cell
type and multiplicity dependent defect which could be interpreted
as arising from inefficient activation of viral gene expression,
leading to a lower probability of initiating a productive infection
(8-11). Rather interestingly, the outcome of infection with these
viruses in the least permissive cell types had many similarities
to latency, in that the Vmwl 10 mutant viral genomes that did
not form plaques were present in the cell in a potentially active
form (12). In addition, it has been clearly demonstrated that
Vmwl 10 is both necessary and sufficient for the reactivation of
latent HSV in an in vitro latency system (13). In contrast, the
evidence that Vmwl 10 plays a role in latency in animal systems
is not so clear cut, although it may be required for reactivation
from explanted ganglia at normal efficiency (14,15). Thus
Vmwl 10 has been implicated in several key aspects of the HSV-1
life cycle.
The study of the biochemical properties and functions of
Vmwl 10 has been hampered by its rather low levels of expression
which presents difficulties for its purification from productively
infected cells. It has been shown that it is a phosphorylated nuclear
protein which is associated with chromatin, and which binds to
calf thymus DNA cellulose columns in crude nuclear extracts
(16,17). Analysis of the predicted amino acid sequence of
Vmwl 10 has identified a cysteine-rich region which conforms
with a consensus sequence of protein domains which can interact
with zinc (18,19). It is significant that this potential zinc finger
of Vmwl 10 is essential for its functions both in transfection assays
(20,21) and in the viral genome (10,22). Recently, the potential
zinc finger of Vmwl 10 has been found to be a representative
of a class of such elements which is very highly conserved in
a number of proteins of diverse evolutionary origin (23). Many
of these proteins have been implicated to have roles in important
processes, some involving different aspects of DNA metabolism
and cell development (24—29). Therefore further investigation
of the properties of Vmwl 10 is pertinent not only to the study
of HSV-1, but also to the understanding of the function of its
highly conserved crucial region.
This paper reports the use of a baculovirus vector to achieve
high level expression of Vmwl 10 using derivative of the IE-1
gene from which the intron sequences had been removed. The
protein has been extensively purified and some of its biochemical
characteristics analysed. We found that preparations of Vmwl 10
contain dimers and perhaps higher order oligomers, and that
although the purified protein interacts with both double and single
stranded DNA on a solid cellulose support, it does not appear
to form a stable complex with DNA in solution.
MATERIALS AND METHODS
Plasmids
Plasmid pAClll (Figure IB) was used for the insertion of the
Vmwl 10 coding region under the control of the baculovirus
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polyhedrin gene promoter into the baculovirus genome. It was
derived from the Ncol-Sall coding region fragment of pi IOC 1,
an intron-less derivative of the IE-1 gene of plasmid p i l l (30),
and the Sall-Hpal region of pJR3 (4), which includes the 3'
portion of the IE-1 gene. Initially, a Sall-HindlH fragment of
pJR3 (which includes the Sall-Hpal portion) and the Ncol-Sall
IE-1 coding region fragment of pi 10C1 were ligated into the Ncol
and Hindlll sites of p585.4, a derivative of pET8c (31) to create
pT7110. The Ncol-Hpal IE-1 coding region of pT7110 was
isolated, blunt ended with Klenow polymerase and ligated into
the similarly blunt ended BamHI cloning site of plasmid pAcYMl
(32; Figure 1), thus creating pACll l . All plasmids were
maintained in E. coli strain HB101.
Construction of a recombinant baculovirus expressing
VmwllO
Plasmid pAClll was digested with PvuII (sites not shown on
Figure IB), which produces a linear fragment containing the
recombinant VmwllO gene flanked by Autographa californica
nuclear polyhedrosis virus (AcNPV) viral DNA, and then
transfected by the calcium phosphate method (33) into Spodoptera
frugiperda (Sf) cells with infectious AcNPV DNA (kindly
provided by Dr. N.D. Stow). The progeny virus stock was
harvested, and the required recombinant isolated by enrichment
during several rounds of growth of aliquoted dilutions in multiwell
dishes followed by plaque purification. At all stages the presence
of the recombinant gene containing the Vmwl 10 coding region
was assessed by Southern blot analysis (34), of either Xhol or
EcoRI digested total cellular DNA isolated by phenol and
chloroform extraction (35). The probe used was pACll l . The
required virus contained a characteristic 2.45kb Xhol fragment
which includes the 5' portion of the polyhedrin gene linked to
the IE-1 coding sequences. The insertion of the 2.8kb IE-1
sequences, which contain no EcoRI sites, into the polyhedrin gene
(which has had the internal 0.75kb deleted in vector pAcYMl)
increases the size of the AcPNV EcoRI I fragment from 7.4kb
to 9.4kb. The virus in the medium was retained as a stock to
carry through to the next round of purification. Plaque purification
was continued until the stock of recombinant virus (ACV110)
contained no trace of contaminating wild type AcNPV genomes.
Purification of VmwllO
(a) Expression and nuclear extract preparation. Sf cells
(approximately 2x 107 per flask) were seeded into 800ml tissue
culture flasks with 25ml TC100 medium (Flow Laboratories)
supplemented with 5% Foetal calf serum and the antibiotics
penicillin and streptomycin. At the same time ACVI10 was added
at a multiplicity of 2 pfu per cell. The flasks were incubated at
28°C for 3 days. The cells were shaken from the plastic into
the medium and harvested by centifugation. The medium was
retained as virus stock for use in subsequent experiments. Nuclear
extracts were prepared as described (36).
(b) Phosphocellulose chromatography. Nuclear extract from 16
flasks (4ml) was diluted with an equal volume of 50mM Hepes
pH 7.0, 10% glycerol, 5mM beta mercaptoethanol and lmM
PMSF (Buffer A), and then applied to a 5ml phosphocellulose
column equilibrated with Buffer A plus 0.2M NaCl. After
washing with 4 aliquots of 5ml of the equilibration buffer, proteins
were eluted with successive steps of Buffer A containing 0.25M,
0.3M, 0.4M and finally 1.0M NaCl. Each ionic strength used
4 aliquots of 5ml of the buffer. Vmwl 10 eluted principally in
the 0.25M and 0.3M NaCl steps, as judged by SDS
polyacrylamide gel electrophoresis (SDS-PAGE).
(c) Q-sepharose chromatography. The appropriate 0.25M and
0.3M NaCl fractions from the phosphocellulose column were
mixed and applied directly to a 2ml Q-sepharose column
equilibrated with Buffer A plus 0.25M NaCl. After extensive
washing with the equilibration buffer, most contaminating
proteins were eluted by Buffer A containing 0.3M NaCl. The
column was washed with Buffer A containing 0.4M then 1.0M
NaCl, using 4 aliquots of lml at all stages. Vmwl 10 eluted in
the 0.4M NaCl fractions was judged to be at least 75% pure by
examination of SDS polyacrylamide gels stained with Coomassie
blue.
SDS polyacrylamide gel electrophoresis
Discontinuous SDS polyacrylamide gels were cast in a BioRad
Mini Protean II gel kit using buffers and solutions as
recommended by the supplier. Separation gel concentrations were
either 7.5% or 10% acryiamide. The molecular weight markers
(SDS-6H, Sigma) used were myosin, 205kD; beta galactosidase,
116kD; phosphorylase b, 97kD; bovine serum albumin, 66kD;
egg albumin, 45kD and carbonic anhydrase, 29kD. The gels were
stained with Coomassie blue, destained and photographed using
Kodak ortholith film.
Western blotting to detect VmwllO
SDS-polyacrylamide gels were cast in a Bio-Rad mini gel kit.
After electrophoretic separation, the proteins were transferred
to nitrocellulose sheets using the compatible Bio-Rad western
blotting apparatus. The sheets were blocked at 37°C using 3%
gelatin, and then incubated overnight with rabbit antipeptide
serum 14711 at a dilution of 1 in 10. Antibody 14711 was raised
against a synthetic peptide which corresponds to a sequence near
the carboxy terminus of Vmwl 10 (18). After washing off excess
antiserum, the bound antibody was detected using horseradish
peroxidase conjugated to protein A.
ELISA quantitation of VmwllO
Plastic microtitre dishes were incubated overnight with samples
which had been diluted with PBS as appropriate. The wells were
then washed, blocked with PBS containing Tween 20 at 0.02%,
washed again and then incubated at 37°C for 1 hour with a 1/1000
dilution of rabbit antiserum 14711. After extensive washing, the
wells were incubated with horseradish peroxidase linked to
protein A and again extensively washed. The bound peroxidase
was detected by incubation with the colourigenic substrate ABTS;
colour development was quantitated using a microtitre plate
reader.
Glycerol gradient centrifugation
Gradients containing 5-20% glycerol in Buffer A plus 0.4M
NaCl were made in 5ml centifuge tubes. Samples containing
approximately 5/ig of purified Vmwl 10 were layered onto the
gradients with 20/*g of thyroglobulin (19S), yeast alcohol
dehydrogenase (6.7S) and bovine serum albumin (4.3S) as
markers. After centifugation at 30,000 rpm for 19 hours, 0.2ml
samples were taken sequentially from the top of the gradient with
a wide bore pipette. These were analysed by SDS-PAGE and
ELISA to detect VmwllO and the marker proteins.
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DNA cellulose chromatography
Double stranded and single stranded DNA cellulose slurries
(Sigma) were prepared in Buffer A plus 0.1M NaCl and packed
into 0.2ml columns. Purified VmwllO in the same buffer was
applied and the column washed with buffers of increasing salt
concentration as described in the text. All operations were
performed in the cold. Fractions were collected and assayed for
VmwllO by SDS-PAGE and ELISA.
Nitrocellulose filter DNA binding assays
Nitrocellulose filter circles (0.45/*m pore size, Schleicher and
Scheull) were boiled in distilled water and then soaked in Buffer
A supplemented with 50mM NaCl and 50/tg/ml BSA (binding
buffer). A probe was prepared by cutting plasmid pgDCAT (37)
with Hindlll, PvuII and EcoRI and then labelling with Klenow
polymerase and alpha 32P dATP. The labelled fragments were
purified by phenol and chloroform extraction and ethanol
precipitation. Column fractions from the VmwllO purification
procedure were incubated with the probe fragment mixture in
binding buffer at 0°C for 20 minutes and then filtered through
the nitrocellulose. Filters were washed several times with lml
aliquots of binding buffer. The amount of radioactivity retained
on the filter was determined by scintillation counting. In some
instances, the fragments retained on the filters were eluted by
incubation with TE buffer containing 0.5% SDS, ethanol
precipitated and then analysed on polyacrylamide gels followed
by autoradiography.
RESULTS
Construction of a recombinant baculovirus containing the
Vmwl 10 coding region under the control of the polyhedrin gene
promoter.
The predicted 775 amino acid residue Vmwl 10 coding region
of HSV-1 IE gene 1 lies in the repeats bounding the long unique
segment of the genome and is interrupted by two intervening
sequences (Figure 1A). The constuction of an intron-less version
of this coding region in plasmid pi 10C1 has been described
previously (10). The Ncol to Hpal IE-1 coding region of pi 10C1
was transferred to the transfer plasmid pAcYMl (Figure IB),
which contains a section of the baculovirus genome with a BamHI
cloning site 3' of the polyhedrin gene promoter (32). The resultant
plasmid was linearised and transfected into Sf cells with infectious
baculovirus DNA. The progeny virus stocks were screened for
the desired recombinant (as described in detail in the methods
section). Virus ACV110, which contains the intronless Vmwl 10
gene (Figure IB), was extensively purified and its genome in
the region of the expression site thoroughly checked by Southern
blotting. Its structure was as predicted (data not shown).
Virus ACV110 expresses large amounts of VmwllO
Wild type AcNPV and ACV110 were used to infect Sf cells at
a multiplicity of 2 pfu per cell and parallel plates harvested at
various times for analysis by SDS-PAGE. The results showed
that ACV110 expressed, at late times of infection, copious
amounts of a protein with the mobility expected of VmwllO.
The optimal time to harvest the cells was three days after infection
(data not shown).
The expression of Vmwl 10 was investigated in more detail
by preparing cytoplasmic and nuclear extracts of the infected cells
three days after infection. These extracts were again compared
with parallel extracts made from wild type virus infected cells.
The results (Figure 2A) illustrate the expression of Vmwl 10 by
ACV110 (indicated by the upper arrow) and that it is present
principally in the nucleus. The most heavily staining band in the
wild type virus infected cell extracts is the polyhedrin protein
(which is near the bottom of the gel). As expected, this protein
is not expressed by ACV110, and, while ACV110 expresses
rather less Vmwl 10 than wild type expresses polyhedrin, the
amounts of VmwllO accumulated are considerable.
VmwllO was not the only additional band appearing in the
ACV110 infected cell nuclear extracts. The other major
differences from the wild type virus infected cells are a band
at about 35kd (lower arrow in Figure 2A, middle arrow in
Figure 2B) and another of low molecular weight (lower arrow
in Figure 2B). It is not known if these represent breakdown
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Figure 1. A map of the IE-1 region of HSV-1 and the baculovirus transfer vector
pAClll . A. The HSV-1 genome is shown with the repeat sequences marked
as boxes. Gene IE-1 lies in the repeat bounding the long unique genome segment.
Below is an expansion of the IE-1 region annotated with key restriction sites and
the transcribed portion (including the introns) of IE-1. The numbering is of the
RL sequence (18). B. Plasmid pAcYMl contains a section of ACV EcoRI
fragment I cloned into pUC8. An intron-less IE-1 coding region Ncol-Hpal
fragment was inserted into the BamHI site 3' of the polyhedrin gene promoter
to create pAC 111. The transcript derived from the recombinant gene is predicted
to express Vmwl 10 from its natural ATG initiation codon. The Xhol site in the
AcNPV vector DNA is marked; there is another 315bp from the Ncol site in
IE-1 DNA. The 2.4kb predicted Xhol fragment was used as a screen for
recombinant baculovirus genomes which contained the IE-1 coding region.
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Figure 2. Recombinant virus ACV110 expresses Vmwl 10. A. Whole cell (WC),
cytoplasmic (C), nuclear (N) and insoluble (P) fractions of Sf cells which had
been infected for 72 hours with ACV 110 and AcNPV wild type virus separated
on a Coomassie blue stained 7.5% SDS polyacrylamide gel. The molecular weight
markers (MW) are myosin (2O5kD), beta galactosidase (116kD), phosphorylase
b (97kD), bovine serum albumin (66kD), egg albumin (45kD) and carbonic
anhydrase (29kD). The upper arrow points out Vmwl 10 and the lower indicates
another prominent band not present in the wild type vims nuclear extract. The
major stained band in the whole cell and pellet fractions of AcNPV extracts at
about 30kD is the polyhedrin protein. B. Nuclear extracts of AcNPV and A-
CV110 separated on a 12.5% SDS polyacrylamide gel The molecular weight
markers are bovine serum albumin (66kD), egg albumin (45kD), glyceraldehyde
3 phosphate dehydrogenase (36kD), carbonic anhydrase (29kD), trypsinogen
(24kD) and trypsin inhibitor (20kD). The uppermost of the three arrows indicates
Vmwl 10 while the others indicate proteins not present in ACV WT extracts.
C. A western blot of samples of HSV-1 infected (HSV) and uninfected (BHK)
cells and ACV 110 infected and uninfected (Sf) cells using rabbit antiserum 14711.
The arrow points out undegraded Vmwl 10.
B
110 .01 .02 M
10 IS
Fraction number
Figure 4. Preparations of purified Vmwl 10 contain dimers. A. Glycerol gradient
centrifugation of Q-sepharose purified Vmwl 10. Vmwl 10 was detected by ELISA
using serum 14711 and the marker proteins by SDS-PAGE. The positions of
the peaks fractions of the marker proteins, and their sedimentation co-efficients,
are indicated. B. Glutaraldehyde cross linking of Vmwl 10. Q-sepharose purified
Vmwl 10 (110) was treated with 01 and .02% final concentrations of
glutaraldehyde and then analysed on a 5% SDS polyacrylamide gel. The lower
arrow indicates monomenc Vmwl 10, migrating slightly faster than the beta
galactosidase marker, while the upper points out the dimer band, co-migrating
with the myosin marker. Note also the material of very low mobility in the
glutaraldehyde treated tracks, which is not present in the untreated control.
N w « b 0-Z5M N»CI M OJM N«C1 <UM UIM M
I II
B NE PC QS M
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Figure 3. Purification of Vmwl 10. A. The elution profile of an ACV 110 infected
cell nuclear extract (N) separated by successive steps of increasing ionic strength
(as indicated) on a phosphocellulose column and analysed on 10% SDS
polyacrylamide gels. The molecular weight markers (M) are as in Figure 2A.
Vmwl 10 is indicated by the arrow. B. A 10% SDS polyacrylamide gel stained
with Coomassie blue showing ACV 110 infected cell nuclear extract (NE), pooled
fractions after phosphocellulose column chromatography (PC) and a sample after
purification on a Q-sepharose column (QS). Molecular weight markers (M) are
as in Figure 2A.
products of Vmwl 10, cellular proteins that become preferentially
eluted from the nucleus in the presence of Vmwl 10, or cellular
proteins which are induced by the high level expression of
Vmwl 10.
It was important to compare the Vmwl 10 proteins expressed
by ACV110 and by HSV-1. Accordingly, BHK cells were
infected with HSV-1 and harvested 16 hours later. Samples of
the HSV-1 and ACV 110 infected cells were analysed by SDS-PA-
GE with samples of mock infected BHK and Sf cells for
comparison. The proteins were transferred to nitrocellulose by
Western blotting and Vmwl 10 detected after incubation with
rabbit antiserum 14711, which recognises a carboxy terminal
peptide of Vmwl 10 (10), followed by horseradish peroxidase
conjugated protein A. The results (Figure 2C) show that the
Vmwl 10 expressed by ACV110 is of the same mobility as that
expressed by HSV-1, and that it possesses the same carboxy
terminal epitope. These data suggest that the Vmwl 10 expressed
by ACVI10 is very similar to that expressed during HSV-1
infection. The bands of lower molecular weight in the ACV110
track of Figure 2C are probably degradation products of Vmwl 10
since they are not present in the Sf cell control.
Purification of VmwllO from ACV110 infected cells
Vmwl 10 was extensively purified from nuclear extracts of A-
CV110 infected cells by two steps of column chromatography.
As described in the methods section, nuclear extracts were diluted
with Buffer A without sodium chloride in order to reduce the
ionic strength to 0.2M. The solution was then loaded onto a
phosphocellulose column equilibrated in the same buffer. After
extensive washing, bound proteins were eluted with sequential
steps of Buffer A containing 0.25, 0.3, 0.4 and 1.0M NaCl.
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Figure 5. Purified Vmwl 10 binds to single and double stranded DNA cellulose
columns. Vmwl 10 was loaded onto the indicated columns and eluted by increasing
ionic strength as shown. The amount of Vmwl 10 in each fraction was determined
by ELISA.
Vmwl 10 was detected by SDS-PAGE and was found principally
in the 0.3M step elution (Figure 3A). For the second step,
fractions from the 0.25M and 0.3M NaCl step elutions were
pooled and loaded directly onto a Q-sepharose column
equilibrated with Buffer A containing 0.275M NaCl. The column
was again washed and bound proteins eluted with steps of 0.3M,
0.4M and 1.0M NaCl. Fractions containing Vmwl 10 with a high
degree of purity were eluted at 0.4M NaCl. A summary of these
results, showing the initial extract, the pooled phosphocellulose
fractions and the protein eluted from the Q-sepharose column
is shown in Figure 3B.
Preparations of purified Vmwl 10 contain ditneric molecules
The purified Vmwl 10 preparation illustrated in Figure 3B was
analysed by glycerol gradient centrifugation. Gradients were
loaded with a sample that contained Vmwl 10 and control proteins
bovine serum albumin, yeast alcohol dehydrogenase and bovine
thyroglobulin. After centrifugation fractions were collected from
the top of the tubes, and those containing the marker proteins
were identified by SDS-PAGE (data not shown). Suitable amounts
of the fractions were used to coat wells for an ELISA estimation
of the amount of Vmwl 10 using rabbit antiserum 14711. The
results are shown in Figure 4A. Yeast ADH has a native
molecular weight of 150kD and a sedimentation coefficient of
6.7S. Vmwl 10 is clearly sedimenting with a peak position of
slightly higher S value (8.2S) than ADH. This is consistent with
the presence of dimeric Vmwl 10 molecules. To investigate this
further, the purified Vmwl 10 preparation was incubated in the
presence of 0.01% glutaraldehyde at room temperature for 1
hour. Subsequent SDS-PAGE showed that glutaraldehyde
treatment resulted in the appearance small amounts of a protein
of exactly twice the apparent molecular weight of Vmwl 10
(Figure 4B). Thus it is clear that the preparation of Vmwl 10
contains dimeric molecules. However, treatment with
glutaraldehyde also converted some of the input protein into
material with very low gel mobility, seen as faint bands at the
top of the treated tracks, which is not present in the control track.
Thus it is possible that higher order multimers of Vmwl 10 can
also be formed. Glutaraldehyde treatment of control proteins
I probe
Figure 6. Analysis of the DNA binding activity in nuclear extracts from ACV110
infected and uninfected Sf cells. A gel retardation experiment using equal amounts
of ACV 110 and uninfected cell nuclear extracts with the IE-3 EcoRI-BamHI probe
and increasing amounts of polydl/polydC competitor.
known to be monomeric in solution did not produce novel bands
at the position expected of dimers (data not shown).
Analysis of Vmwl 10 by SDS-PAGE in the absence of reducing
agent indicated that the dimers or multimers were not covalently
linked by disulphide bridges (data not shown). Attempts to
characterise further the nature of purified Vmwl 10 using native
polyacrylamide gel electrophoresis were not successful; the
protein migrated as a high molecular weight smear (data not
shown).
Purified Vmwl 10 binds to both single stranded and double
stranded DNA cellulose matrices
One of the crucial questions about the properties of Vmwl 10
is whether it interacts directly with DNA, and, if so, whether
this interaction is sequence specific. Earlier experiments had
shown that Vmwl 10 in crude nuclear extracts is retained on calf
thymus DNA cellulose columns (17). However, this could be
explained by an interaction between Vmwl 10 and one or more
proteins which were binding to the column. The binding of
Vmwl 10 to both single stranded and double stranded DNA
cellulose was investigated using the purified preparation. The
results (Figure 5) showed that the protein did indeed bind to DNA
cellulose, eluting mainly at salt concentrations higher than 0.2M,
and that its binding to double stranded DNA was essentially
indistinguishable from its binding to single stranded DNA. These
results show that Vmwl 10 can interact directly with DNA.
(Vmwl 10 prepared from HSV-1 infected BHK cells does not
bind to cellulose slurries; unpublished data).
Purified Vmwl 10 does not appear to form a stable complex
with DNA in solution
That Vmwl 10 binds to DNA cellulose columns does not
necessarily imply that it is a DNA binding protein, because its
retention by these columns could be explained by a non-specific
electrostatic interaction, in the same way that it binds to
phosphocellulose. Therefore several attempts were made to
investigate whether purified Vmwl 10 interacts with DNA in
solution. Initial experiments adopted gel retardation technology
to compare the DNA binding activities of nuclear extracts of A-
CV110 infected and uninfected cells. The probe contained the
IE-3 promoter region from coordinates —108 to +27, and the
methods were exactly as described (38). The results (Figure 6)
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load FT 02 0.25 0.25 0 J OJ 0.4 1.0
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Figure 7. The DNA binding activity in ACV110 infected cell nuclear extracts
does not co-purify with Vmwl 10. A nuclear extract containing Vmwl 10 was
fractionated on phosphocellulose and Q-sepharose columns as indicated. The load,
flowthrough, 0.2M, 0.25M (2 aliquots), 0.3M (2 aliquots), 0.4M and 1.0M NaCI
samples were used to detect the amount of Vmwl 10 by ELISA (open boxes)
and the amount of DNA binding activity in filter binding experiments (filled boxes).
The vertical scale on the display on the left refers to the DNA binding activity
(cpmx 10~3), normalised for the amount of protein in each sample. That to the
left of the righthand display gives the amount of Vmwl 10 ELISA units.
showed that nuclear extracts containing Vmwl 10 displayed a
similar general or non-specific DNA binding potential to
uninfected nuclear extracts. Both contained sufficient DNA
binding activity to form complexes of low mobility (which
probably contain many different proteins) in the absence of
competitor polydl/polydC. Increasing the amount of competitor
resolved bands of higher mobility, but there was no indication
of any major differences between the two types of extract.
A gel retardation experiment of necessity can investigate
binding to only a limited set of DNA sequences. Therefore a
filter binding assay, using of a mixture of probe fragments derived
from plasmid pgDCAT, was also used. Plasmid pgDCAT
responds to activation by Vmwl 10 in transfection experiments
(37). The probe fragments were incubated with the ACVI10
nuclear extract and the mixture filtered through nitrocellulose.
The DNA fragments bound to the filter by proteins in the extract
were eluted with SDS and analysed on polyacrylamide gels. There
was no preferential retention of any of the fragments; all were
equally sensitive to competition by the addition of increasing
amounts of polydl/polydC (results not shown). These results
suggests that Vmwl 10 does not bind with high affinity to any
specific DNA sequences in pgDCAT, but (taken with the results
of the gel retardation experiment) they do not exclude the
possibility that Vmwl 10 has a non-specific DNA binding ability
which was masked by the total DNA binding capacity of the crude
nuclear extract (Figure 6).
Therefore, the DNA binding activity in fractions throughout
the Vmwl 10 purification procedure was measured by filter
binding experiments using the pgDCAT probe mixture. The
amount of Vmwl 10 in each fraction was quantitated by ELISA.
The results (Figure 7) showed that fractions from the
phosphocellulose column contained DNA binding activity, but
binding was not proportional to the amount of Vmwl 10 in the
fractions. The 0.25M and 0.3M NaCI step fractions from the
phosphocellulose column were pooled and passed down a Q-
seharose column. The binding activity clearly eluted with a peak
at a much lower ionic strength than the Vmwl 10 elution peak.
Indeed, DNA binding activity in the peak Vmwl 10 fractions was
essentially undetectable. These data can not be explained by
inactivation of the DNA binding activity of VmwlO during Q-
sepharose chromatography since the recoveries of both Vmwl 10
and DNA binding activity were about 70%. The assays using
the peak Vmwl 10 fractions contained a final salt concentration
(90mM) which did not inhibit binding of Vmwl 10 to DNA
cellulose columns (Figure 5). The fractions containing purified
Vmwl 10 were also completely inactive in a gel retardation
experiment in the absence of polydl/polydC competitor (results
not shown).
These results strongly suggest that purified Vmwl 10 is unable
to form a stable complex with DNA in solution. It did not display
non-specific DNA binding activity under a variety of conditions.
If it were a sequence specific DNA binding protein, even if its
recognition site is not present in a plasmid which responds to
its activity, it would be expected to bind to other DNA sequences
in a plasmid the size of pgDCAT in the absence of competitor.
DISCUSSION
A fundamental understanding of the mechanism of action of
Vmwl 10 has been impeded by its low level of expression during
a normal virus infection; it has been difficult to obtain the protein
in any great quantity or purity. The construction of a baculovirus
recombinant which expresses large quantities of Vmwl 10, and
the subsequent isolation of highly purified preparations of the
protein, is a first step towards a detailed understanding of its
biochemistry and its interactions with other macromolecules. This
paper describes the initial steps towards this goal: we have found
that Vmwl 10 forms multimers, including dimers, in solution and
that it is apparently unable to form a stable interaction with DNA
in solution.
The interaction of Vmwl 10 with DNA is of considerable
interest given its role in transcriptional activation. This study
confirms a previous finding that Vmwl 10 binds to DNA cellulose
columns (17) and extends it to show that highly purified protein
is still able to bind, both to double and single stranded DNA.
However, the key question is whether this binding represents a
simple ionic interaction with the phosphate backbone of DNA,
a non-specific interaction with the nucleotide bases, or a specific
interaction with a defined sequence of bases. There is no evidence
of any sequence specific interaction, since the DNA binding
activity of extracts containing Vmwl 10 could not be shown to
select any specific sequence from fragments comprising a plasmid
which responds to activation by Vmwl 10. Perhaps this is not
surprising as no specific sequences have been defined which are
required for activation by Vmwl 10. If Vmwl 10 interacts non-
specifically with the nucleotide bases, this interaction must be
sufficiendy weak to be undetectable by a non-specific filter
binding assay conducted under conditions which would allow
binding of a wide range of DNA binding proteins (Figure 7).
Therefore, since Vmwl 10 binds to negatively charged matrices
during purification, it seems likely that its retention on DNA
cellulose columns is simply a reflection of this ionic interaction.
It follows that its ability to activate gene expression is likely to
result from an interaction with other proteins or macromolecules.
As illustrated by a number of recent observations, activation
of gene expression can be achieved without direct interaction with
DNA by a variety of different mechanisms. These include:
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activation of a bound cellular transcription factor (39,40); removal
of repressors complexed to transcription factors (41—44);
modification of the DNA binding specificity of a transcription
factor (45), and inhibition of the formation of a restrictive
chromatin structure (46). The availability of large amounts of
purified VmwllO should enable studies to determine which (if
any) of these stategies it employs.
A further area of interest with respect to Vmwl 10 is the recent
discovery that a potential zinc finger domain within its second
exon is very highly conserved among a number of proteins of
diverse evolutionary origin (23-29). Some of these proteins seem
to be involved in a number of different aspects of DNA
metabolism and gene expression. The highly conserved nature
of the potential zinc finger (which is distinguishable from the
two other well described classes of zinc finger) suggests that it
is involved in a process of general importance. It has been
suggested, as cited above, that the conserved motif might be
involved in DNA sequence recognition since it is similar to other
zinc finger motifs which perform this function. However, the
results presented here imply that DNA binding is not the role
of at least this member of this particular class of zinc finger. The
availability of purified preparations of one member of this family
of proteins will enable investigations relevent not only to herpes
viruses and gene regulation, but also to a wide range of other
aspects of DNA function.
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